Connect with us

Hi, what are you looking for?

Business News

European drug regulator backs mixing COVID-19 vaccines

Pedestrians wear masks to prevent the spread of the COVID-19 as they walk past a store decorated as part of Christmas lightings, in Paris, Monday, Dec. 6, 2021. The new potentially more contagious omicron variant of the coronavirus popped up in more European countries just days after being identified in South Africa, leaving governments around the world scrambling to stop the spread. (AP Photo/Christophe Ena)

THE HAGUE, Netherlands (AP) — The European Union drug regulator gave its backing Tuesday to mixing different types of vaccines in initial vaccination and booster campaigns to battle the coronavirus.

The European Medicines Agency said in a statement that using different types of vaccines together, known as heterologous vaccination, can provide protection against COVID-19.

The announcement comes as much of Europe is facing rising infection and hospital rates and concerns about the new omicron variant.

The EMA, together with the European Center for Disease Prevention and Control, said that a mix-and-match strategy could give nations more options in vaccination campaigns as much of the continent seeks to contain the latest surge in the pandemic.

“The evidence available so far with different types of authorized vaccines indicates that a heterologous booster appears as good as or better in terms of immune responses than a homologous booster,” the agencies said in a statement.

“While research is ongoing to provide more evidence on long-term safety, duration of immunity and effectiveness, the use of heterologous schedules may offer flexibility in terms of vaccination options, particularly to reduce the impact on the vaccine rollout should a vaccine not be available for any reason,” they added.

The agencies looked at data for mRNA vaccines like the Pfizer shot and so-called viral vector vaccines such as the one made by Johnson & Johnson. The two types of vaccines use different technologies to spur the body to fight the coronavirus.

U.S. and U.K. authorities have already given the green light to mixing and matching vaccines in booster campaigns.

“The evidence available so far with different types of authorized vaccines indicates that a heterologous booster appears as good as or better in terms of immune responses than a homologous booster,” the agencies said in a statement.

“While research is ongoing to provide more evidence on long-term safety, duration of immunity and effectiveness, the use of heterologous schedules may offer flexibility in terms of vaccination options, particularly to reduce the impact on the vaccine rollout should a vaccine not be available for any reason,” they added.

The agencies looked at data for mRNA vaccines like the Pfizer shot and so-called viral vector vaccines such as the one made by Johnson & Johnson. The two types of vaccines use different technologies to spur the body to fight the coronavirus.

U.S. and U.K. authorities have already given the green light to mixing and matching vaccines in booster campaigns.


Copyright 2021 Associated Press. All rights reserved.

Source: https://apnews.com/article/coronavirus-pandemic-health-europe-european-union-f347ffeeb4708bf4882cf21c8947c04c

Advertisement. Scroll to continue reading.
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Business News

EUGENE, Ore. (AP) — Psilocybin tea, wind chimes and a tie-dye mattress await those coming to an office suite in Eugene to trip on...

Business News

WASHINGTON (AP) — President Joe Biden is trumpeting Medicare’s new powers to negotiate directly with drugmakers on the cost of prescription medications — but a poll shows that...

Health News

Resistant starch is a nondigestible fiber that ferments in the large intestine, and consumption of it has previously been shown to have a positive...

Business News

The Brenner Base Tunnel will form the main part of a 64 km mega-tunnel under the Alps between Austria and Italy, making it the...

Copyright © 2023 Newsworthy News | Global | Political | Local | All News | Website By: Top Search SEO